Form D · Biotechnology

MediProPharma, Inc.

Midvale, UT · CIK 0001474737

Offering snapshot reported Nov 13, 2009 · SEC filing

Reported sold
$645K
Offering amount: $770K
Investors reported
8
Form D · investor count
Minimum accepted
$1K
Reported outside-investor minimum
First sale
Oct 1, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$323K$645KOct 16, 2009: $645,000.00Oct 16, 2009Nov 13, 2009: $645,000.00Nov 13, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 13, 2009Amendment$645,000$0vs Oct 16, 20098SEC filing
Oct 16, 2009Initial$645,000No comparison8SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-135403

Source: Form D, filed Nov 13, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shane A. Johnson Director
Thomas N. Parker Director
Thomas N. Parks Director
Irina Shcherbakova Director, Executive
S. George Simon Director, Executive
Theodore H. Stanley Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
359 East Union Mill Drive
Midvale, UT, 84047